⌕
Transmedics Group · TMDX · Nasdaq
Tenet 60 · Solid
Compare
$91.38−0.67%At closeTenet 60 · Solid
$91.38−0.62 (−0.67%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Transmedics Group (TMDX) Stock

Transmedics Group (TMDX) closed at $91.38 on Nov 13, 2026; its Tenet Score is 60 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

6 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$91.38
Nov 13, 2026
Market cap
$3.2B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
25.8×
price ÷ earnings
52-week range
60.10 – 156.00
low → high
Tenet Score
60/100
Solid · 409 Healthcare peers

Industry: Health Services · see every company filed here →

Transmedics Group Inc scores 60/100. Solid. Strongest on growth, value is the soft spot, trading at 26× earnings versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
60/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
36
Quality
63
Health
52
Growth
91

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityCHealthCGrowthAMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
5.8×
price to book value
P/S
4.4×
price to fiscal 2025 sales
ROE
32%
return on equity
Operating margin
17.9%
fiscal 2025, before interest and tax
Net margin
19.9%
of revenue kept
Current ratio
4.53
current assets to liabilities
Net debt / EBITDA
0.1×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Transmedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable or…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 107 US ETFs · top wrappers by weightSee all ETFs holding TMDX →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Transmedics Group in?

Transmedics Group is in the Healthcare sector and the Health Services industry.

What is Transmedics Group's Tenet Score?

Transmedics Group's Tenet Score is 60 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.